Psoriasis vulgaris
Conditions
Interventions
control group:Placebo
Sponsors
Shaanxi Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine for guttate or plaque psoriasis and the diagnostic criteria for TCM syndromes of psoriasis; 2. Skin lesions involving <=10% BSA; 3. PASI score<=12; 4. Aged 18-65 years, gender is not limited; 5. Those who agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those with other active skin diseases that may affect the assessment of the condition; 2. Have systematically received treatment with investigational drugs, biological agents and immunosuppressive agents within 1 month; 3. Received topical corticosteroids, phototherapy and other treatments within 2 weeks; 4. In a state of severe and uncontrollable local or systemic acute or chronic infection; 5. Patients with severe systemic diseases; or patients whose clinical test indicators belong to one of the following conditions: increased alanine aminotransferase or aspartate aminotransferase > 1.5 times the upper limit of normal; increased creatinine > the upper limit of normal; any one of the main indicators of blood routine (white blood cell count, hemoglobin concentration, platelet count) > the upper limit of normal value; or other abnormal laboratory examinations in patients who are not suitable for participating in this trial; 6. Patients with a history of malignant tumors and patients with primary or secondary immunodeficiency and hypersensitivity; 7. Have undergone major surgery within 8 weeks or will require such surgery during the study; 8. Pregnant or lactating patients; 9. Those with a history of alcohol, drug or drug abuse; 10. Those with a history of serious mental illness or family history; 11. Participate in other clinical trials; 12. For other reasons, the researcher believes that it is not suitable to participate in this researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| psoriasis area and severity index; | — |
Secondary
| Measure | Time frame |
|---|---|
| body surface area;visual analogue scale;dermatology life quality index;recurrence rate;onset time; | — |
Countries
China
Contacts
Public ContactZhao Yiding
Shaanxi Traditional Chinese Medicine Hospital
Outcome results
None listed